CPT vs ESPR · P/E 104, rev $7.1M vs rev $332.3M
Camden Property Trust (CPT) versus Esperion Therapeutics Inc (ESPR) — a side-by-side from cached financials, not a winner call.
Camden Property Trust (CPT) is a reit - residential company listed on US.
Esperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CPT revenue for 2024-12-31 was $7.1M. Net income was $170.8M. Revenue was up 106.8% from 2023-12-31 to 2024-12-31. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
Latest reported ESPR revenue for 2024-12-31 was $332.3M. Net income was -$51.7M. Revenue was up 185.7% from 2023-12-31 to 2024-12-31. ESPR currently screens at market cap $816.9M.
CPT currently screens at market cap $12.11B and trailing P/E 104.0. ESPR currently screens at market cap $816.9M.
Not investment advice. Open the CPT and ESPR stock pages for the full models.
Not investment advice.